Key Documents

View All Documentation

474347

3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctyl acrylate

Name: 3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctyl acrylate
Brand: ALDRICH

contains inhibitor, 97%

Synonym(s):

1H,1H,2H,2H-perfluorooctyl acrylate, TFOA

Select a Size

Change View

About This Item

Linear Formula:

H₂C=CHCO₂CH₂CH₂(CF₂)₅CF₃

CAS Number:

17527-29-6

Molecular Weight:

418.15

NACRES:

NA.23

PubChem Substance ID:

24870991

UNSPSC Code:

12162002

EC Number:

241-527-8

MDL number:

MFCD00042351

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

Quality Level

100

assay

97%

contains

HQ, MEHQ as inhibitor

refractive index

n20/D 1.338 (lit.)

bp

76-80 °C/8 mmHg (lit.)

density

1.554 g/mL at 25 °C (lit.)

storage temp.

2-8°C

SMILES string

FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CCOC(=O)C=C

InChI

1S/C11H7F13O2/c1-2-5(25)26-4-3-6(12,13)7(14,15)8(16,17)9(18,19)10(20,21)11(22,23)24/h2H,1,3-4H2

InChI key

VPKQPPJQTZJZDB-UHFFFAOYSA-N

Description

pictograms

GHS08,GHS09

signalword

Warning

hcodes

H373,H410

pcodes

P260 - P273 - P314 - P391 - P501

Hazard Classifications

Aquatic Chronic 1 - STOT RE 2

target_organs

Liver,Teeth

Storage Class

10 - Combustible liquids

wgk

WGK 1

flash_point_f

215.6 °F - closed cup

flash_point_c

102 °C - closed cup

ppe

Eyeshields, Gloves, type ABEK (EN14387) respirator filter

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Nonpharmacological and nonsurgical approaches in OA.

Sita Bierma-Zeinstra et al.

Best practice & research. Clinical rheumatology, 34(2), 101564-101564 (2020-08-11)

Osteoarthritis (OA) is a chronic, disabling, and common disease. Nonpharmacological and nonsurgical treatments are seen as the core treatments for OA. This paper presents an overview of the recommendations from international guidelines on nonpharmacological and nonsurgical interventions. Education, advice, or

Changes in clinical symptoms and functional disability in patients with coexisting patellofemoral and tibiofemoral osteoarthritis: a 1-year prospective cohort study.

Hirotaka Iijima et al.

BMC musculoskeletal disorders, 18(1), 126-126 (2017-03-28)

This 1-year prospective cohort study aimed to compare the changes in clinical symptoms and functional disability between patients with coexisting patellofemoral (PF) and tibiofemoral (TF) osteoarthritis (OA) and those with isolated TFOA. Seventy-two patients with medial knee OA were enrolled.

pH-Induced Switchable Superwettability of Efficient Antibacterial Fabrics for Durable Selective Oil/Water Separation.

Yuchen Fu et al.

ACS applied materials & interfaces, 9(35), 30161-30170 (2017-08-15)

The superhydrophobic antibacterial fabrics with intelligent switchable wettability were fabricated by the cross-link reaction among pH-responsive antibacterial copolymer tethered hydroxyl groups, methylol-contained poly(ureaformaldehyde) nanoparticles (PUF NPs), and hexamethylene diisocyanate. It was found that the surface concentration of N

View All Related Papers

Global Trade Item Number

SKU	GTIN
474347-25ML	04061837407710
474347-5ML	04061832361208